The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | Werth Peter J. | Director | Grant(A) | 20K | — | $0 |
| Jul 16, 2026 | Silva Raul R. | EVP and CSO | Grant(A) | 54K | — | $0 |
| Jul 16, 2026 | Silva Raul R. | EVP and CSO | Grant(A) | 26K | — | $0 |
| Jul 16, 2026 | Schaffer Shane J. | Chief Executive Officer, Director | Grant(A) | 198K | — | $0 |
| Jul 16, 2026 | Schaffer Shane J. | Chief Executive Officer, Director | Grant(A) | 97K | — | $0 |
| Jul 16, 2026 | Downey Bryan Wade | EVP & Chief Commercial Officer | Grant(A) | 67K | — | $0 |
| Jul 16, 2026 | Downey Bryan Wade | EVP & Chief Commercial Officer | Grant(A) | 33K | — | $0 |
| Jul 16, 2026 | Lawrence Bryan Jay | Director | Grant(A) | 20K | — | $0 |
| Jul 16, 2026 | Brams Matthew | EVP and Chief Medical Officer | Grant(A) | 54K | — | $0 |
| Jul 16, 2026 | Brams Matthew | EVP and Chief Medical Officer | Grant(A) | 26K | — | $0 |
| Jul 16, 2026 | Hargroves Thomas Jeffrey | Director | Grant(A) | 20K | — | $0 |
| Jul 16, 2026 | Callahan Jennifer L. | EVP and CFO | Grant(A) | 40K | — | $0 |
| Jul 16, 2026 | Callahan Jennifer L. | EVP and CFO | Grant(A) | 20K | — | $0 |
| Jun 30, 2026 | Silva Raul R. | EVP and CSO | Grant(A) | 4K | — | $0 |
| Mar 31, 2026 | Silva Raul R. | EVP and CSO | Grant(A) | 3K | — | $0 |
| Mar 9, 2026 | Hargroves Thomas Jeffrey | Director | Grant(A) | 15K | — | $0 |
| Mar 9, 2026 | Brams Matthew | EVP and Chief Medical Officer | Tax withholding(F) | 1K | — | $0 |
| Mar 9, 2026 | Brams Matthew | EVP and Chief Medical Officer | Grant(A) | 5K | — | $0 |
| Mar 9, 2026 | Callahan Jennifer L. | EVP and CFO | Tax withholding(F) | 6K | — | $0 |
| Mar 9, 2026 | Callahan Jennifer L. | EVP and CFO | Grant(A) | 15K | — | $0 |
| Mar 9, 2026 | Patel Nilay Dahyabhai | EVP, CLO and CCO | Tax withholding(F) | 2K | — | $0 |
| Mar 9, 2026 | Patel Nilay Dahyabhai | EVP, CLO and CCO | Grant(A) | 5K | — | $0 |
| Mar 9, 2026 | Schaffer Shane J. | Chief Executive Officer, Director | Tax withholding(F) | 3K | — | $0 |
| Mar 9, 2026 | Schaffer Shane J. | Chief Executive Officer, Director | Grant(A) | 7K | — | $0 |
| Mar 9, 2026 | Silva Raul R. | EVP and CSO | Grant(A) | 5K | — | $0 |
| Mar 9, 2026 | Silva Raul R. | EVP and CSO | Tax withholding(F) | 2K | — | $0 |
| Feb 13, 2026 | Hargroves Thomas Jeffrey | Director | Buy(P) | 97K | $5.04 | $490K |
| Feb 13, 2026 | Hargroves Thomas Jeffrey | Director | Buy(P) | 78K | $0.10 | $8K |
| Feb 6, 2026 | Brams Matthew | EVP and Chief Medical Officer | Buy(P) | 2K | $5.04 | $10K |
| Feb 6, 2026 | Brams Matthew | EVP and Chief Medical Officer | Buy(P) | 2K | $0.10 | $156 |
| Feb 6, 2026 | Schaffer Shane J. | Chief Executive Officer, Director | Buy(P) | 7K | $5.04 | $34K |
| Feb 6, 2026 | Schaffer Shane J. | Chief Executive Officer, Director | Buy(P) | 5K | $0.10 | $545 |
| Feb 6, 2026 | Callahan Jennifer L. | SVP and CFO | Buy(P) | 5K | $5.04 | $25K |
| Feb 6, 2026 | Callahan Jennifer L. | SVP and CFO | Buy(P) | 4K | $0.10 | $389 |
| Feb 6, 2026 | Werth Peter J. | Director | Buy(P) | 19K | $5.04 | $98K |
| Feb 6, 2026 | Werth Peter J. | Director | Buy(P) | 16K | $0.10 | $2K |
| Dec 31, 2025 | Silva Raul R. | EVP and CSO | Grant(A) | 7K | — | $0 |
| Nov 3, 2025 | Downey Bryan Wade | Chief Commercial Officer | Grant(A) | 30K | — | $0 |
| Sep 30, 2025 | Silva Raul R. | EVP and CSO | Grant(A) | 7K | — | $0 |
| Jul 8, 2025 | Patel Nilay Dahyabhai | CLO and CCO | Grant(A) | 30K | — | $0 |
| Jul 7, 2025 | Brams Matthew | EVP and Chief Medical Officer | Grant(A) | 53K | — | $0 |
| Jul 7, 2025 | Callahan Jennifer L. | SVP and CFO | Grant(A) | 65K | — | $0 |
| Jul 7, 2025 | Myers Laurie | EVP and COO | Grant(A) | 31K | — | $0 |
| Jul 7, 2025 | Schaffer Shane J. | Chief Executive Officer, Director | Grant(A) | 200K | — | $0 |
| Jul 7, 2025 | Silva Raul R. | EVP and CSO | Grant(A) | 52K | — | $0 |
| Jun 30, 2025 | Silva Raul R. | EVP and CSO | Grant(A) | 1K | — | $0 |
| Jun 20, 2025 | Ervin Jeffrey S | Director | Grant(A) | 15K | — | $0 |
| Jun 20, 2025 | Lawrence Bryan Jay | Director | Grant(A) | 15K | — | $0 |
| Jun 20, 2025 | Roberts John A | Director | Grant(A) | 15K | — | $0 |
| Jun 20, 2025 | Werth Peter J. | Director | Grant(A) | 15K | — | $0 |
| Mar 31, 2025 | Silva Raul R. | EVP and CSO | Grant(A) | 1K | — | $0 |
| Feb 18, 2025 | Silva Raul R. | EVP and CSO | Grant(A) | 18K | — | $0 |
| Feb 18, 2025 | Brams Matthew | EVP and Chief Medical Officer | Grant(A) | 18K | — | $0 |
| Feb 18, 2025 | Myers Laurie | EVP and COO | Grant(A) | 18K | — | $0 |
| Feb 18, 2025 | Schaffer Shane J. | Chief Executive Officer, Director | Grant(A) | 70K | — | $0 |
| Feb 18, 2025 | Callahan Jennifer L. | SVP and CFO | Grant(A) | 21K | — | $0 |
| Jan 17, 2025 | Brams Matthew | EVP and Chief Medical Officer | Grant(A) | 3K | — | $0 |
| Jan 17, 2025 | Schaffer Shane J. | Chief Executive Officer, Director | Grant(A) | 28K | — | $0 |
| Jan 17, 2025 | Myers Laurie | EVP and COO | Grant(A) | 9K | — | $0 |
| Jan 17, 2025 | Silva Raul R. | EVP and CSO | Grant(A) | 3K | — | $0 |
| Jan 17, 2025 | Callahan Jennifer L. | SVP and CFO | Grant(A) | 12K | — | $0 |
| Dec 31, 2024 | Brams Matthew | EVP and Chief Medical Officer | Grant(A) | 1K | — | $0 |
| Dec 31, 2024 | Silva Raul R. | EVP and CSO | Grant(A) | 1K | — | $0 |
| Sep 30, 2024 | Brams Matthew | EVP and Chief Medical Officer | Grant(A) | 1K | — | $0 |
| Sep 30, 2024 | Silva Raul R. | EVP and CSO | Grant(A) | 1K | — | $0 |
| Aug 15, 2024 | Myers Laurie | EVP and COO | Sell(S) | 202 | $4.17 | $842 |
| Jun 28, 2024 | Brams Matthew | EVP and Chief Medical Officer | Grant(A) | 1K | — | $0 |
| Jun 28, 2024 | Silva Raul R. | EVP and CSO | Grant(A) | 1K | — | $0 |
| Jun 12, 2024 | Ervin Jeffrey S | Director | Grant(A) | 10K | — | $0 |
| Jun 12, 2024 | Lawrence Bryan Jay | Director | Grant(A) | 10K | — | $0 |
| Jun 12, 2024 | Roberts John A | Director | Grant(A) | 10K | — | $0 |
| Jun 12, 2024 | Werth Peter J. | Director, 10% Owner | Grant(A) | 10K | — | $0 |
| Jun 11, 2024 | Ervin Jeffrey S | Director | Grant(A) | 14K | — | — |
| Jun 11, 2024 | Ervin Jeffrey S | Director | Grant(A) | 5K | — | $0 |
| Jun 11, 2024 | Brams Matthew | EVP and Chief Medical Officer | Grant(A) | 63K | — | $0 |
| Jun 11, 2024 | Lawrence Bryan Jay | Director | Grant(A) | 5K | — | $0 |
| Jun 11, 2024 | Lawrence Bryan Jay | Director | Grant(A) | 14K | — | — |
| Jun 11, 2024 | Callahan Jennifer L. | SVP and CFO | Grant(A) | 95K | — | $0 |
| Jun 11, 2024 | Roberts John A | Director | Grant(A) | 5K | — | $0 |
| Jun 11, 2024 | Roberts John A | Director | Grant(A) | 15K | — | — |
| Jun 11, 2024 | Myers Laurie | EVP and COO | Grant(A) | 99K | — | $0 |
| Jun 11, 2024 | Schaffer Shane J. | Chief Executive Officer, Director | Grant(A) | 218K | — | $0 |
| Jun 11, 2024 | Silva Raul R. | EVP and CSO | Grant(A) | 63K | — | $0 |
| Jun 11, 2024 | Werth Peter J. | Director, 10% Owner | Grant(A) | 7K | — | — |
| Apr 11, 2024 | Werth Peter J. | Director, 10% Owner | Option exercise(M) | 342K | — | $0 |
| Apr 11, 2024 | Werth Peter J. | Director, 10% Owner | Option exercise(M) | 694K | — | $0 |
| Apr 11, 2024 | Werth Peter J. | Director, 10% Owner | Option exercise(M) | 342K | — | $0 |
| Apr 11, 2024 | Werth Peter J. | Director, 10% Owner | Option exercise(M) | 694K | — | $0 |
| Mar 29, 2024 | Silva Raul R. | EVP and CSO | Grant(A) | 1K | — | $0 |
| Mar 29, 2024 | Brams Matthew | EVP and Chief Medical Officer | Grant(A) | 1K | — | $0 |
| Mar 25, 2024 | Werth Peter J. | Director, 10% Owner | Other(J) | 7K | — | — |
| Mar 4, 2024 | Lawrence Bryan Jay | Director | Grant(A) | 5K | — | $0 |
| Mar 4, 2024 | Callahan Jennifer L. | SVP and CFO | Grant(A) | 25K | — | $0 |
| Mar 4, 2024 | Ervin Jeffrey S | Director | Grant(A) | 5K | — | $0 |
| Mar 4, 2024 | Myers Laurie | EVP and COO | Grant(A) | 26K | — | $0 |
| Mar 4, 2024 | Brams Matthew | EVP and Chief Medical Officer | Grant(A) | 17K | — | $0 |
| Mar 4, 2024 | Werth Peter J. | Director | Grant(A) | 2K | — | — |
| Mar 4, 2024 | Roberts John A | Director | Grant(A) | 5K | — | $0 |
| Mar 4, 2024 | Schaffer Shane J. | Chief Executive Officer, Director | Grant(A) | 57K | — | $0 |
| Mar 4, 2024 | Silva Raul R. | EVP and CSO | Grant(A) | 17K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Cingulate Inc., SEC CIK 0001862150. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under CING and shows every filing by that issuer.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for CING